Delivery Order SPE2DR25D2005-SPE2DR26FF0Y8
Award Date 1/16/26
Potential Completion Date 1/20/26
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $6,947.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 15, 2025, with completion scheduled for December 16, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $1 billion and extending through December 2026. The vaccine product will be...
- The Defense Logistics Agency awarded a $9,451.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for TYPHIM VI 25 MCG/0.5 ML vaccine syringes. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a $7,153 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on January 18, 2026, with an ultimate completion date of January 20, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was not set aside for any specific business type and was competitively awarded. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a $1,936.91 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 12, 2025, with completion expected by December 15, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine delivery will be performed at the contractor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,732.82 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this...
- The Defense Logistics Agency awarded a $3,576.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringe vaccine product on January 13, 2026, with completion targeted for January 14, 2026. This is an unrestricted, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,009.25 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringe vaccine product on December 29, 2025, with a completion date of December 30, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $1 billion and extending through December 2026. The...
- The Defense Logistics Agency awarded a $8,645.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of TYPHIM VI 25 MCG/0.5 ML syringe vaccine product. This is a non-set-aside contract with an ultimate completion date of January 13, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency (DLA) awarded a $14,306 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order represents a single shipment of this typhoid vaccine product, with performance to be completed by January 14, 2026, and fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora,...
- The Defense Logistics Agency (DLA) awarded a $100,185 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 16, 2025, with an ultimate completion date of December 17, 2025. This firm fixed-price contract represents a non-competitive delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The product will be performed at AmerisourceBergen's corporate...